HLCS Gene - Holocarboxylase Synthetase

Genetic and Functional Insights into Biotin Metabolism

Gene Information Card

Symbol HLCS
Full Name Holocarboxylase Synthetase (biotin-[propionyl-CoA-carboxylase (ATP-hydrolysing)] ligase)
Gene Type Protein coding
Chromosomal Location 21q22.13
NCBI Gene ID 3141 ncbi.nlm.nih.gov/gene/3141
Ensembl ID ENSG00000159267
UniProt ID P50747
OMIM ID 609018
HGNC ID 4976
Aliases HCS, biotin-protein ligase

Description

The HLCS gene encodes holocarboxylase synthetase, a biotin-protein ligase that catalyzes the covalent attachment of biotin to specific lysine residues in carboxylase enzymes. This biotinylation is essential for the activity of multiple carboxylases involved in gluconeogenesis, fatty acid synthesis, and amino acid catabolism. Mutations in HLCS cause holocarboxylase synthetase deficiency (multiple carboxylase deficiency), an autosomal recessive disorder of biotin metabolism.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Holocarboxylase synthetase deficiency Loss-of-function mutations impair biotinylation of carboxylases, leading to metabolic acidosis and organic aciduria ClinVar, OMIM
Multiple carboxylase deficiency Deficient biotin attachment to propionyl-CoA carboxylase, pyruvate carboxylase, and 3-methylcrotonyl-CoA carboxylase OMIM, NCBI Gene
Biotin-responsive multiple carboxylase deficiency Some HLCS mutations respond to high-dose biotin supplementation ClinVar

Expression Profile

Tissue Expression
Tissue nTPM level
Liver 12.5 Medium
Kidney 8.3 Medium
Brain 5.1 Low
Heart 6.7 Low
Skeletal muscle 3.2 Low
Cell Line Expression
Cell Line nTPM Notes
HepG2 15.2 Hepatocellular carcinoma cell line
HEK293 10.8 Embryonic kidney cells
K562 7.4 Leukemia cell line
A549 6.1 Lung carcinoma cells
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.1522C>T (p.Arg508Trp) Missense Common in European populations Loss of biotin-binding affinity
c.1648G>A (p.Val550Met) Missense Rare Reduced enzymatic activity
c.1990C>T (p.Arg664Cys) Missense Reported in multiple families Impaired biotinylation
c.2341delG (p.Ala781Profs*13) Frameshift Rare Premature truncation, loss of function
Mutation functional classification

Loss of Function (LOF)

Most HLCS mutations are loss-of-function, reducing or abolishing biotin ligase activity.

Gain of Function (GOF)

No gain-of-function mutations reported.

Dominant Negative (DN)

No dominant-negative effects described; disease is autosomal recessive.

Pathways

Biotin metabolism (Reactome: R-HSA-196780)
Metabolism of vitamins and cofactors (Reactome: R-HSA-196849)

Protein Summary

Holocarboxylase synthetase (HCS) is a 726-amino acid protein that uses ATP to catalyze the biotinylation of apocarboxylases. It contains a biotin-binding domain and a catalytic domain. The enzyme is critical for activating biotin-dependent carboxylases in multiple metabolic pathways. Deficiency leads to metabolic acidosis, ketosis, and neurological symptoms, often treatable with biotin supplementation.

Related Products

Product name Cat.No. Species Gene ID
HLCS Knockout HEK293 Cell Line EDJ-KQ13759 Human 3141 Details Get a Quote
HLCS Knockout HeLa Cell Line EDJ-KQ18052 Human 3141 Details Get a Quote
HLCS Knockout A-549 Cell Line EDJ-KQ43541 Human 3141 Details Get a Quote
HLCS Knockout HCT 116 Cell Line EDJ-KQ43542 Human 3141 Details Get a Quote
Displaying Records 1 To 4 Of 4 Records
Contact Us
*
*
*
*
How did you hear about us: